MYLAN LABS LTD FDA Approval ANDA 202970

ANDA 202970

MYLAN LABS LTD

FDA Drug Application

Application #202970

Application Sponsors

ANDA 202970MYLAN LABS LTD

Marketing Status

Discontinued001

Application Products

001TABLET;ORAL-280.03MG,0.04MG,0.03MG;0.05MG,0.075MG,0.125MG0LEVONORGESTREL AND ETHINYL ESTRADIOLETHINYL ESTRADIOL; LEVONORGESTREL

FDA Submissions

UNKNOWN; ORIG1AP2018-03-23
LABELING; LabelingSUPPL3AP2022-04-29STANDARD

Submissions Property Types

ORIG1Null7
SUPPL3Null7

CDER Filings

MYLAN LABS LTD
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 202970
            [companyName] => MYLAN LABS LTD
            [docInserts] => ["",""]
            [products] => [{"drugName":"LEVONORGESTREL AND ETHINYL ESTRADIOL","activeIngredients":"ETHINYL ESTRADIOL; LEVONORGESTREL","strength":"0.03MG,0.04MG,0.03MG;0.05MG,0.075MG,0.125MG","dosageForm":"TABLET;ORAL-28","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"03\/23\/2018","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2018-03-23
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.